| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272702.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.033265796 |
Resistant |
| ENSG00000272702.1 |
Crizotinib |
Brain lower grade glioma |
0.038117154 |
Resistant |
| ENSG00000272702.1 |
Crizotinib |
Skin cutaneous melanoma |
0.004388924 |
Sensitive |
